Physician
Endocrinology
Dr. Alan S. Krasner, MD
|
|
Give Review
Alan S. Krasner works in the field of Endocrinology. He researched medicine at Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine is ranked 19/29 in Research/PrimaryCare. Alan Krasner is a published MD as well. He has 19 publications published. The latest was: Primary ovarian carcinoid: value of octreotide scintigraphy for diagnosis and correlation with other cross-sectional imaging modalities and pathology. He accepts all Medicare patients.
Publications
- Development of stable liquid glucagon formulations for use in artificial pancreas.
- A review of a family of ultra-rapid-acting insulins: formulation development.
- Immunological responses to exogenous insulin.
- Insulin antibodies with pulmonary delivery of insulin.
- Development and validation of radioligand binding assays to measure total, IgA, IgE, IgG, and IgM insulin antibodies in human serum.
- Development and validation of a radioligand binding assay to measure insulin specific IgG subclass antibodies in human serum.
- Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 Diabetes.
- Cloning and chromosomal localization of the human BARX2 homeobox protein gene.
- The gene encoding Xenopus embryonic epidermal keratin XK70A exhibits a hybrid Type I-Type II intron pattern.
- Primary ovarian carcinoid: value of octreotide scintigraphy for diagnosis and correlation with other cross-sectional imaging modalities and pathology.
- Glucocorticoid-induced adrenal insufficiency.
- Anaplastic pseudoThyroiditis.
- Assessment of long-term immunological and pulmonary safety of inhaled human insulin with up to 24 months of continuous therapy.
- Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 Diabetes: A 3-year randomized contr...
- Antibody response to inhaled insulin in patients with type 1 or type 2 Diabetes. An analysis of initial phase II and III inhaled insulin (Exubera) trials and a two-yea...
- Body weight changes associated with insulin therapy: a retrospective pooled analysis of inhaled human insulin (Exubera) versus subcutaneous insulin in five controlled ...
- The effect of insulin antibodies on the metabolic action of inhaled and subcutaneous insulin: a prospective randomized pharmacodynamic study.
- Apoplexy in a recurrent pituitary adenoma.
Schools
Northwestern Center Feinberg School of Medicine
Johns Hopkins Hospital
Conditions Treated
- Diabetes Type 2
- Goiter
- Hyperlipidemia
- HyperparaThyroidism
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Pathway X Ind PPO Direct Access CT
- Blue Card PPO
- Blue Choice
- Commercial Insurance Company
- Connecticare HMO
- Connecticare POS
- GHI PPO
- Empire Blue Cross Blue Shield HMO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Freedom Plan
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- Oxford Liberty
- United Healthcare
Education
-
Johns Hopkins University -
Northwestern University Feinberg School of Medicine
Drug Facts
| NPI NUMBER | 1932211562 | |
| NPPES Provider LastName | KRASNER | |
| NPPES Provider FirstName | ALAN | |
| NPPES Provider ZIPCode | 063204700 | |
| NPPES Provider State | CT | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 149.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1932211562 |
| Last Name Of The Provider | KRASNER |
| First Name Of The Provider | ALAN |
| View All |
Similar Doctors
|
|
Dr. Robert P. Lamberton, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rita R. Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|